The necessity for routine histopathologic evaluation of hemorrhoidectomy specimens considered free of suspicious areas after careful visual and manual inspection remains controversial.
The purpose of this work was to prospectively study the prevalence of anal intraepithelial neoplasia in macroscopically normal operative specimens.
From October 2005 to September 2010, all hemorrhoidectomy and fissurectomy specimens were sent for routine histopathologic analysis.
This study was conducted at a tertiary referral center.
The primary outcome measured was the histopathologic examination of surgical samples.
Among the specimens from 2997 procedures, routine histopathologic evaluation found anal intraepithelial neoplasia in 97 patients (3.2%), despite the fact that visual and manual inspection had determined that the specimens were free of any suspected anal intraepithelial neoplasia or human papillomavirus-related lesion. The pathological diagnoses for these macroscopically normal specimens were AIN1 in 22 (23%) patients, AIN2 in 48 (49%) patients and AIN3 in 27 (28%) patients, making the prevalence of high-grade and low-grade disease 2.5% (anal intraepithelial neoplasia 2/3) and 0.7% (anal intraepithelial neoplasia 1).
This study was limited by being a single-center study.
This prospective single-center study demonstrated that the prevalence of infraclinical anal intraepithelial neoplasia in macroscopically normal hemorrhoidectomy and fissurectomy specimens is not negligible (3.2% with 2.5% high-grade disease).
1 Service de Proctologie Médico-Interventionnelle, Groupe Hospitalier Diaconesses Croix-Saint-Simon, Paris, France
2 Service d’Anatomie et de Cytologie pathologiques, Hôpital Saint-Antoine, Paris, France
Funding/Support: This study was supported by a research grant from the Société Nationale Française de Gastroentérologie
Financial Disclosure: None reported.
Poster presentation at the meeting of The American Society of Colon and Rectal Surgeons, Hollywood, FL, May 17 to 21, 2014. Presented at Journées Francophones d’Hépatogastroentérologie et d’Oncologie Digestive Meeting, Paris, France, March 20 to 23, 2014.
* The Proctological Prospective Diaconesses Group: P. Atienza, M. Barret, B. Bertrand, J. Bourguignon, H. Bouzid, Z. Dahmani, N. Fathallah, M. Fourti, M. Gauquelin, L. Hafit, N. Hoyau, C.L. Johan, M. Ksiaa, A.C. Lesage, N. Meary, F. Mesli, B. Mory, N. Mourra, K. Nabib, M. Nourani, M. Ould-Hocine Lazrak, V. de Parades, N. Rabahi, H. Safafar, S. Sultan, M. Taouk, C. Thomas, D. Wendum, and J.D. Zeitoun.
Correspondence: Isabelle Etienney, M.D., Groupe Hospitalier Diaconesses-Croix Saint-Simon, 125 rue d’Avron, 75020 Paris, France. E-mail: firstname.lastname@example.org